U.S. federal trademark · Serial No. 76232019
Bioassay system containing four phenotypes-dopaminergic, GABAergic, serotonergic and cholinergic neurons, used to determine whether small molecules, proteins, and/or conditioned media from cells selectively prevent death of nerve cells
Bioassay services, namely, services to detect specific neurotrophic factors in clinical research
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.